{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:18:19Z","timestamp":1760188699674,"version":"3.44.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2754,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.virol.2005.09.057","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T18:48:05Z","timestamp":1135277285000},"page":"240-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["New viral vaccines"],"prefix":"10.1016","volume":"344","author":[{"given":"Ann M.","family":"Arvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry B.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2001.0918","article-title":"Varicella vaccine: genesis, efficacy, and attenuation","volume":"284","author":"Arvin","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.09.057_bib2","series-title":"Fields' Virology","first-page":"2731","article-title":"Varicella-zoster virus","author":"Arvin","year":"2001"},{"issue":"1\u20132","key":"10.1016\/j.virol.2005.09.057_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2004.02.031","article-title":"Current status of live attenuated influenza virus vaccine in the US","volume":"103","author":"Belshe","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2005.09.057_bib4","series-title":"Vaccines","first-page":"371","article-title":"Influenza vaccines\u2014Live","author":"Belshe","year":"2004"},{"issue":"20","key":"10.1016\/j.virol.2005.09.057_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.virol.2005.09.057_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"9394","key":"10.1016\/j.virol.2005.09.057_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(03)14687-9","article-title":"Rotavirus antigenaemia and viraemia: a common event?","volume":"362","author":"Blutt","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virol.2005.09.057_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"9\u201310","key":"10.1016\/j.virol.2005.09.057_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0264-410X(00)00316-9","article-title":"Humoral and cell-mediated immunity to vero cell-derived influenza vaccine","volume":"19","author":"Bruhl","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.virol.2005.09.057_bib11","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.virol.2005.09.057_bib12","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","article-title":"Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product","volume":"89","author":"Chellappan","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2003.10.054","article-title":"Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants","volume":"144","author":"Clark","year":"2004","journal-title":"J. Pediatr."},{"issue":"Suppl. 10","key":"10.1016\/j.virol.2005.09.057_bib14","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/01.inf.0000142370.16514.4a","article-title":"A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis","volume":"23","author":"De Vos","year":"2004","journal-title":"Pediatr. Infect Dis. J."},{"issue":"6","key":"10.1016\/j.virol.2005.09.057_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.inf.0000164763.55558.71","article-title":"Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine","volume":"24","author":"Dennehy","year":"2005","journal-title":"Pediatr. Infect Dis. J."},{"key":"10.1016\/j.virol.2005.09.057_bib16","unstructured":"Dubin, G., Zahaf, T., C.B., Quint, W., Martin, M., Jenkins, D., 2005 \"Cross-Protection Against Persistent HPV Infection, Abnormal Cytology and CIN Associated with HPV-16 and 18 Related HPV Types by a HPV 16\/18 L1 Virus-Like Particle Vaccine [abstract]. 22nd International Papillomavirus Conference and Clinical Workshop."},{"issue":"15","key":"10.1016\/j.virol.2005.09.057_bib17","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/JVI.76.15.7832-7842.2002","article-title":"Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine","volume":"76","author":"Emeny","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.09.057_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/0470846534.ch6","article-title":"Pathogenesis of rotavirus gastroenteritis","volume":"238","author":"Estes","year":"2001","journal-title":"Novartis Found. Symp."},{"year":"2004","series-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalance Worldwide","author":"Ferlay","key":"10.1016\/j.virol.2005.09.057_bib19"},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2001.0830","article-title":"Challenges for rotavirus vaccines","volume":"281","author":"Franco","year":"2001","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2005.09.057_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0952-7915(96)80035-5","article-title":"Immunology of papillomavirus infection","volume":"8","author":"Frazer","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virol.2005.09.057_bib22","series-title":"Vaccines","first-page":"339","article-title":"Influenza vaccines-inactivated","author":"Fukuda","year":"2004"},{"key":"10.1016\/j.virol.2005.09.057_bib23","doi-asserted-by":"crossref","unstructured":"Gershon, A.A., 2001. Live-attenuated varicella vaccine. Infect Dis. Clin. North Am. 15 (1) 65\u201381, viii.","DOI":"10.1016\/S0891-5520(05)70268-3"},{"issue":"9","key":"10.1016\/j.virol.2005.09.057_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.virol.2005.09.057_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/aje\/kwg163","article-title":"Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures","volume":"158","author":"Halloran","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"7\u20138","key":"10.1016\/j.virol.2005.09.057_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0264-410X(01)00428-5","article-title":"Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children","volume":"20","author":"Halperin","year":"2002","journal-title":"Vaccine"},{"issue":"9447","key":"10.1016\/j.virol.2005.09.057_bib27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.virol.2005.09.057_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/163.4.873","article-title":"Varicella-zoster virus-specific immunity after herpes zoster","volume":"163","author":"Hayward","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2005.09.057_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/368218","article-title":"Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses","volume":"187","author":"He","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virol.2005.09.057_bib31","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI22797","article-title":"T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus","volume":"114","author":"He","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.virol.2005.09.057_bib32","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"17","key":"10.1016\/j.virol.2005.09.057_bib33","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1128\/JVI.79.17.11014-11021.2005","article-title":"Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B\/Ann Arbor\/1\/66","volume":"79","author":"Hoffmann","year":"2005","journal-title":"J. Virol."},{"issue":"9246","key":"10.1016\/j.virol.2005.09.057_bib34","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0140-6736(00)03315-8","article-title":"Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7","volume":"356","author":"Hopfl","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.virol.2005.09.057_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev., Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1542\/peds.2004-0860","article-title":"Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children","volume":"115","author":"Hsu","year":"2005","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.virol.2005.09.057_bib37","first-page":"449","article-title":"Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination","volume":"126","author":"Jarrett","year":"1990","journal-title":"Vet. Rec."},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.virol.2005.09.057_bib39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0264-410X(03)00074-4","article-title":"Novel generations of influenza vaccines","volume":"21","author":"Kemble","year":"2003","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.virol.2005.09.057_bib40","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.virol.2005.09.057_bib41","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/jvi.67.12.6929-6936.1993","article-title":"Efficient self-assembly of human papillomavirus type 16 L1 and L1\u2013L2 into virus-like particles","volume":"67","author":"Kirnbauer","year":"1993","journal-title":"J. Virol."},{"issue":"426","key":"10.1016\/j.virol.2005.09.057_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1651-2227.1999.tb14320.x","article-title":"Seasonality and diversity of Group A rotaviruses in Europe","volume":"88","author":"Koopmans","year":"1999","journal-title":"Acta Paediatr., Suppl."},{"issue":"3","key":"10.1016\/j.virol.2005.09.057_bib43","first-page":"197","article-title":"The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000","volume":"81","author":"Kosek","year":"2003","journal-title":"Bull. World Health Organ."},{"issue":"21","key":"10.1016\/j.virol.2005.09.057_bib44","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.virol.2005.09.057_bib45","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JVI.79.5.2651-2658.2005","article-title":"Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model","volume":"79","author":"Ku","year":"2005","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2005.09.057_bib46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J. Infect. Dis."},{"year":"2004","series-title":"Morbidity and Mortality Weekly Report, Centers for Disease Control","author":"MMWR","key":"10.1016\/j.virol.2005.09.057_bib47"},{"issue":"21","key":"10.1016\/j.virol.2005.09.057_bib48","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papillomavirus-induced oncogenesis","volume":"78","author":"Munger","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.virol.2005.09.057_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.virol.2005.09.057_bib51","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/367895","article-title":"Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions","volume":"187","author":"Murphy","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.virol.2005.09.057_bib52","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.virol.2005.09.057_bib53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.virol.2005.09.057_bib55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/spid.2002.125862","article-title":"The future of rotavirus vaccines","volume":"13","author":"Offit","year":"2002","journal-title":"Semin. Pediatr. Infect Dis."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.spid.2005.12.008","article-title":"A millennium update on pediatric diarrheal illness in the developing world","volume":"16","author":"O'Ryan","year":"2005","journal-title":"Semin. Pediatr. Infect Dis."},{"issue":"22","key":"10.1016\/j.virol.2005.09.057_bib57","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI0215999","article-title":"Influenza vaccines: present and future","volume":"110","author":"Palese","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.virol.2005.09.057_bib59","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg. Infect Dis."},{"issue":"17","key":"10.1016\/j.virol.2005.09.057_bib60","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199710233371701","article-title":"Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela","volume":"337","author":"Perez-Schael","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2005.09.057_bib61","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/431511","article-title":"Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants","volume":"192","author":"Phua","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"17\u201319","key":"10.1016\/j.virol.2005.09.057_bib62","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/rmv.448","article-title":"Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine","volume":"15","author":"Santos","year":"2005","journal-title":"Rev. Med. Virol."},{"issue":"3","key":"10.1016\/j.virol.2005.09.057_bib64","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.virol.2005.09.057_bib65","first-page":"59","article-title":"Ano-genital neoplasia in renal transplant patients","volume":"2","author":"Sillman","year":"1997","journal-title":"Ann. Transplant."},{"issue":"9289","key":"10.1016\/j.virol.2005.09.057_bib66","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(01)06346-2","article-title":"Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception","volume":"358","author":"Simonsen","year":"2001","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2005.09.057_bib67","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and Intussusception: the role of age at the time of vaccination","volume":"192","author":"Simonsen","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virol.2005.09.057_bib68","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.91.12.5320","article-title":"p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein","volume":"91","author":"Slebos","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2005.09.057_bib69","first-page":"265","article-title":"Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation","volume":"13","author":"Thomas","year":"1996","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.virol.2005.09.057_bib70","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","article-title":"Rotavirus infections in infants as protection against subsequent infections","volume":"335","author":"Velazquez","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.virol.2005.09.057_bib71","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.inf.0000141722.10130.50","article-title":"Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants","volume":"23","author":"Vesikari","year":"2004","journal-title":"Pediatr. Infect Dis. J."},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.virol.2005.09.057_bib73","first-page":"636","article-title":"Frequent display of human papillomavirus type 16 E6-specific memory T-Helper cells in the healthy population as witness of previous viral encounter","volume":"63","author":"Welters","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2005.09.057_bib74","series-title":"Fields Virology","article-title":"Orthomyxoviruses","author":"Wright","year":"2002"},{"issue":"18","key":"10.1016\/j.virol.2005.09.057_bib75","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1073\/pnas.0501045102","article-title":"Varicella-zoster virus infection of human dorsal root ganglia in vivo","volume":"102","author":"Zerboni","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2005.09.057_bib76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(91)90772-4","article-title":"Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles","volume":"185","author":"Zhou","year":"1991","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virol.2005.09.057_bib77","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev., Cancer"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500632X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500632X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:39:30Z","timestamp":1758584370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220500632X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S004268220500632X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.09.057","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New viral vaccines","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}